Agentic AI for Clinical Trial Design and Operations — Breaking the Amendment Cycle
CONCEPTAgentic AI systems are being explored to automate clinical trial operations and reduce the need for protocol amendments—changes that delay trials and complicate regulatory submissions. These systems can coordinate across multiple trial sites, monitor protocol adherence, manage patient communication, and flag issues requiring human review. The "amendment cycle" problem: as trials progress, operational challenges emerge that require protocol modifications. Each amendment requires regulatory approval, site retraining, and participant notification, creating delays and costs. Agentic AI could reduce amendments by proactively identifying and resolving operational issues before they cascade into protocol-level problems. However, deploying autonomous agents in clinical trials requires exceptional governance: these systems must operate within strict regulatory constraints, maintain detailed audit trails, and escalate any decision that could affect patient safety or data integrity. The balance between operational efficiency and regulatory compliance remains a key design challenge. ---
Subscribe to read full wiki analysis
Full wiki content — including source provenance, contradiction tracking, related pages, and analyst notes — is available to Subscriber members.
View Plans & SubscribeNew users get a 7-day trial — no credit card required.